FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOSR Holdings, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSRHW
OSR Holdings, Inc. Stock AnalysisComprehensive stock analysis for OSR Holdings, Inc. (OSRHW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOSRHW
OSRHW
OSR Holdings, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSRHW
  1. Home
  2. Stocks
  3. OSR Holdings, Inc.

OSR Holdings, Inc.

🇺🇸OSRHW•NASDAQ

OSR Holdings, Inc.

🇺🇸OSRHW•NASDAQ
Market cap
$7.82M
Sentiment

Your view on OSRHW

Mkt Cap
$7.82M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About OSR Holdings, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Kuk Hyoun Hwang
Headquarters
10900 NE 4th Street, Bellevue, WA, US
Industry
Biotechnology
Sector
Healthcare
CEO
Kuk Hyoun Hwang
Headquarters
10900 NE 4th Street, Bellevue, WA, US
Description

OSR Holdings, Inc. functions as a blank check enterprise. It was established with the sole objective of identifying and executing various forms of business combinations, such as mergers, stock exchanges, asset acquisitions, stock purchases, or reorganizations, with one or more existing businesses.

The company commenced operations on February 25, 2020, and maintains its headquarters in Bellevue, Washington.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for OSR Holdings, Inc. from FRC's valuation model, read against the market price. OSRHW last traded at $0.03; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for OSR Holdings, Inc.. Starting points for OSR Holdings, Inc.: EPS -$0.36, beta 0.72 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for OSR Holdings, Inc.. OSR Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for OSR Holdings, Inc.. Trailing twelve-month EPS for OSR Holdings, Inc. stands at -$0.36. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrDec 2026Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate-$0.26$0.00$0.00
Low estimate-$0.26$0.00$0.00
High estimate-$0.26$0.00$0.00
No. of analysts100
Year-ago EPS-$0.181-$4.021—
Growth———

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$780000.00$3.11M$71.65M
Low estimate$780000.00$3.11M$71.65M
High estimate$780000.00$3.11M$71.65M
No. of analysts111
Year-ago revenue$381269.00$2.91M—
Growth+104.6%+7.2%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for OSR Holdings, Inc.. OSR Holdings, Inc. has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OSRHW18 companies
Compare OSRHW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • AEONAEON Biopharma, Inc.Biotechnology$6M
  • BOLTBolt Biotherapeutics, Inc.Biotechnology$13M
  • CINGCingulate Inc.Biotechnology$76M
  • CLNNClene Inc.Biotechnology$49M
  • CLRBCellectar Biosciences, Inc.Biotechnology$9M
  • MBIOMustang Bio, Inc.Biotechnology$3M

More Biotechnology companies

  • BYSIBeyondSpring Inc.NASDAQ$19M
  • ARUXFAcrux LimitedOTC$2M
  • ARVNArvinas, Inc.NASDAQ$443M
  • ARWRArrowhead Pharmaceuticals, Inc.NASDAQ$6.1B
  • ASBPAspire Biopharma Holdings, Inc.NASDAQ$910,285
  • ASBPWAspire Biopharma Holdings, Inc.NASDAQ$121,920
  • ASCLFAscletis Pharma Inc.OTC$2.1B
  • ASEP.CNAsep Medical Holdings IncCNQ
  • ASMBAssembly Biosciences, Inc.NASDAQ$458M
  • ASNDAscendis Pharma A/SNASDAQ$17.7B
  • ASPHFAscentage Pharma Group InternationalOTC$3.2B
  • ATAIAtai Life Sciences N.V.NASDAQ$2.7B
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold OSR Holdings, Inc., and how their positions are changing. At a $7.8M market value, institutional positions materially move OSR Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by OSR Holdings, Inc. executives and directors. Shares of OSR Holdings, Inc. have traded between $0.04 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for OSR Holdings, Inc.. Coverage tracks OSR Holdings, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of OSR Holdings, Inc.

OSRHW Analysis
Fair
Past1
Growth2
Health5
Profit4
Value1

News

Latest Market News